UK markets open in 5 hours 4 minutes

GrandVision N.V. (GVNV.AS)

Amsterdam - Amsterdam Delayed price. Currency in EUR
Add to watchlist
27.00-0.05 (-0.18%)
At close: 5:35PM CEST
Full screen
Previous close27.05
Open27.00
Bid0.00 x 0
Ask0.00 x 0
Day's range27.00 - 27.10
52-week range22.60 - 27.10
Volume63,229
Avg. volume73,662
Market cap6.851B
Beta (5Y monthly)0.34
PE ratio (TTM)N/A
EPS (TTM)-0.26
Earnings date26 Feb 2021
Forward dividend & yield0.35 (1.29%)
Ex-dividend date27 Apr 2021
1y target est24.45
  • Globe Newswire

    GrandVision announces carve-out of Rotter Y Krauss as part of Chilean market regulator approval for transaction between EssilorLuxottica and HAL

    GrandVision announces carve-out of Rotter Y Krauss as part of Chilean market regulator approval for transaction between EssilorLuxottica and HAL Schiphol, The Netherlands, 12 April 2021. GrandVision N.V. (Euronext: GVNV) confirms that on Friday 9 April 2021, the Chilean market regulator FNE (Fiscalía Nacional Económica) has cleared the transaction between EssilorLuxottica and HAL for the sale of HAL’s 76.72% interest in GrandVision (the “Transaction”) following the commitment to divest GrandVision’s Chilean operations operating under the banner Rotter Y Kraus. GrandVision’s Chilean operations will be sold to HAL in accordance with the terms of the block trade agreement entered into by HAL and EssilorLuxottica on 30 July 2019 in respect of the Transaction. The carve-out is subject to and will close simultaneously with the closing of the Transaction. The Transaction has been unconditionally cleared in Brazil, Colombia, Mexico, Russia and the United States and conditionally cleared in the EU and Chile. It is still under review in Turkey.GrandVision continues to support EssilorLuxottica with the shared objective to obtain regulatory approval to close the Transaction before 31 July 2021. After the Transaction has been closed, EssilorLuxottica will launch a mandatory cash public offer for all outstanding shares in the Company, in accordance with the applicable Dutch public offer rules. Attachment GrandVision Press Release

  • Globe Newswire

    Court of Appeal rules in favor of GrandVision

    Court of Appeal rules in favor of GrandVision Court of Appeal confirms District Court's ruling / Claims made by EssilorLuxottica fully dismissed Schiphol, The Netherlands, 6 April 2021. Today, the Amsterdam Court of Appeal has dismissed all claims made by EssilorLuxottica SA (Euronext: EL) to receive additional information mainly in relation to GrandVision NV’s (Euronext: GVNV) actions to mitigate the impact of COVID-19 on its business. The ruling confirms the earlier ruling by the District Court on August 24, 2020. The arbitration proceedings initiated by GrandVision against EssilorLuxottica, as communicated on 30 July 2020, are ongoing. These proceedings are confidential and behind closed doors. Today's court ruling is separate and independent from the claims raised by GrandVision in the arbitration proceedings. GrandVision continues to support EssilorLuxottica with the shared objective to obtain regulatory approval for the closure of the Transaction before 31 July 2021. Further announcements will be made if and when required. Attachment GrandVision Press Release

  • EssiLux loses court appeal against takeover target GrandVision
    Reuters

    EssiLux loses court appeal against takeover target GrandVision

    Spectacles maker EssilorLuxottica on Tuesday lost an appeal in its court battle with takeover target GrandVision, removing a possible hurdle for the 7.2 billion euro ($8.5 billion) deal. EssilorLuxottica in August last year lost a Dutch court case in which it had said that GrandVision's decisions to suspend payments to store owners and suppliers and to apply for state aid could give grounds for ending its proposed takeover. The Rotterdam district court at the time said EssiLux had failed to prove its claim that the Dutch operator of eyewear stores had breached the takeover agreement by not asking permission for the actions it took as lockdowns to combat COVID-19 spread throughout Europe.